Xi Wei
No ORCID on file
· 2 papers in corpus
· active 2023-2024
BACKGROUND: Elagolix, an approved non-peptide GnRH antagonist, shows promise in relieving endometriosis-related pain, but its short- and mid-term efficacy and potential side effects are still under investigation. OBJECTIVE: The aim is to p…
eview question / Objective The aim of this study is to comprehensively analyze evidence of elagolix in the treatment of moderateto-severe endometriosis-associated pain.Condition being studied Endometriosis-related pain, such as dysmenorrhea…